Moderna (MRNA) narrowed its full-year revenue outlook on Thursday as the drugmaker's third-quarter t
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Moderna Tightens 2025 Revenue Outlook as Third-Quarter Top-Line Beats Estimates
Published 3 days ago
Nov 6, 2025 at 3:37 PM
Positive
